The 55-second answer
Free scale is real; app is real: weight sync, AI check-ins, provider oversight, GLP-1 tracking. Trading: continuous body-data stream into subscription funnel, “AI-native” chat not clinician, data enrollment in FTC-lawsuit-subject ecosystem. Not a scam; a trade. Take it knowing the terms.
If considering GLP-1, understand what actually moves needle in weight management. And if IBS is part of picture, evidence for gut-brain approaches and clinician care differs materially from app.
What you get
Free scale ($50–$100 value), auto-syncs. Progress visibility—weight, GLP-1 milestones, check-ins visible to you and team. AI support between visits. Provider oversight.
Trade #1: Body data continuous stream
July 29—FTC and state AGs sued Hims, alleging health info shared with Meta/Snap without consent. Unresolved, Hims disputes. Don’t need verdict: when subscription is growth engine, data is asset. Questions: What’s permitted? Can you minimize? What if you cancel?
Trade #2: “AI-native” is funnel-with-clinician
AI-in-funnel: primary interface, protocol-trained, escalates exceptions, clinician behind. Clinician-in-loop: named clinician primary, AI serves their interpretation. Neither dishonest. Problem: first marketed as second. Ask: name your doctor?
Trade #3: Scale measures number that matters least
Daily weight noisiest metric. Outcomes depend: body composition, protein, resistance, sleep, markers. Rapid loss with weak protein/no lifting = classic failure: scale down, rebound up.